Anew Labs
An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.
$290MFunding
LeadH
HSG
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
HSG is the investment firm formerly known as Sequoia China, as identified in Clipto’s financing release. Full-Life also names it in its own announcement.
Recorded funding activity
The recorded activity includes Anew’s AI drug discovery, Clipto’s video-library tools and Math Magic’s generation of 3D models and physical products. Named HSG funds retain their separate identities.
Sources
- Rounds participated in
- 3
- Confirmed lead rounds
- 1 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $501M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionFull-Life Technologies
Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing
$150MSeries D+Debt
Role not disclosedVibrant Therapeutics
Develops intelligent, logic-gated therapeutics for solid tumors
$61MSeries A
Role not disclosed